SCHEMBL21035394

SCHEMBL21035394

O=C(O)[C@@H]1C[C@H](Oc2ccc(C(F)(F)F)cc2)CCN1S(=O)(=O)c1ccc(OCC2CCCCC2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADAM17 P78536 3/20 0.42
MMP1 P03956 3/20 0.42
BRD4 O60885 2/20 0.42
HCRTR1 O43613 2/20 0.41
HCRTR2 O43614 2/20 0.41
KCNQ1 P51787 1/20 0.41
ADRB2 P07550 1/20 0.40
MMP13 P45452 3/20 0.40
MMP2 P08253 2/20 0.40
MAPT P10636 1/20 0.40
BRD2 P25440 1/20 0.39
EPHX2 P34913 2/20 0.39
ALDH1A1 P00352 1/20 0.39
HTT P42858 1/20 0.39
ITGB1 P05556 1/20 0.39
ITGA4 P13612 1/20 0.39
KMT2A Q03164 1/20 0.38
LMNA P02545 1/20 0.38
MMP3 P08254 1/20 0.38
MMP7 P09237 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21035414 1.00 ADAM17 (0.42) ADAM17MMP1BRD4HCRTR1HCRTR2
SCHEMBL21035537 1.00 ADAM17 (0.42) ADAM17MMP1BRD4HCRTR1HCRTR2
SCHEMBL21035415 0.91 HCRTR1 (0.45) ADAM17MMP1BRD4HCRTR1HCRTR2
SCHEMBL21035392 0.91 HCRTR1 (0.45) ADAM17MMP1BRD4HCRTR1HCRTR2
SCHEMBL21035539 0.91 HCRTR1 (0.45) ADAM17MMP1BRD4HCRTR1HCRTR2
SCHEMBL21035511 0.88 MMP1 (0.47) ADAM17MMP1HCRTR1HCRTR2MMP13
SCHEMBL21035512 0.88 MMP1 (0.47) ADAM17MMP1HCRTR1HCRTR2MMP13
SCHEMBL21035541 0.88 GHSR (0.41) ADAM17MMP1BRD4HCRTR1HCRTR2
SCHEMBL21035418 0.88 GHSR (0.41) ADAM17MMP1BRD4HCRTR1HCRTR2
SCHEMBL21035391 0.88 GHSR (0.41) ADAM17MMP1BRD4HCRTR1HCRTR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019104011-A1 CERAMIDE GALACTOSYLTRANSFERASE INHIBITORS FOR THE TREATMENT OF DISEASE BIOMARIN PHARMACEUTICAL INC. (US) 2019-05-31 WO disclosed